Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study
Published in
Thrombosis and haemostasis, vol. 114, no. 3, p. 645-650Publication date
2015Abstract
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
WEITZ, J I et al. Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study. In: Thrombosis and haemostasis, 2015, vol. 114, n° 3, p. 645–650. doi: 10.1160/TH15-02-0131
Main files (1)
Article (Published version)
Identifiers
- PID : unige:75136
- DOI : 10.1160/TH15-02-0131
- PMID : 25994838
